Matches in SemOpenAlex for { <https://semopenalex.org/work/W2919906488> ?p ?o ?g. }
- W2919906488 endingPage "31" @default.
- W2919906488 startingPage "22" @default.
- W2919906488 abstract "Clinical evidence indicates that positive allosteric modulators (PAMs) of GABAA receptors have analgesic benefit in addition to efficacy in anxiety disorders. However, the utility of GABAA receptor PAMs as analgesics is compromised by the central nervous system side effects of non-selective potentiators. A selective potentiator of GABAA receptors associated with α2/3 subunits, KRM-II-81(5-(8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepin-3-yl)oxazole), has demonstrated anxiolytic, anticonvulsant, and antinociceptive effects in rodents with reduced motoric side effects. The present study evaluated the potential of KRM-II-81 as a novel analgesic. Oral administration of KRM-II-81 attenuated formalin-induced flinching; in contrast, diazepam was not active. KRM-II-81 attenuated nociceptive-associated behaviors engendered by chronic spinal nerve ligation (L5/L6). Diazepam decreased locomotion of rats at the dose tested in the formalin assay (10 mg/kg) whereas KRM-II-81 produced small decreases that were not dose-dependent (10-100 mg/kg). Plasma and brain levels of KRM-II-81 were used to demonstrate selectivity for α2/3- over α1-associated GABAA receptors and to define the degree of engagement of these receptors. Plasma and brain concentrations of KRM-II-81 were positively-associated with analgesic efficacy. GABA currents from isolated rat dorsal-root ganglion cultures were potentiated by KRM-II-81 with an ED50 of 32 nM. Measures of respiratory depression were reduced by alprazolam whereas KRM-II-81 was either inactive or produced effects with lower potency and efficacy. These findings add to the growing body of data supporting the idea that α2/3-selective GABAA receptor PAMs will have efficacy and tolerability as pain medications including those for neuropathic pain. Given their predicted anxiolytic effects, α2/3-selective GABAA receptor PAMs offer an additional inroad into the management of pain." @default.
- W2919906488 created "2019-03-11" @default.
- W2919906488 creator A5009056923 @default.
- W2919906488 creator A5021570300 @default.
- W2919906488 creator A5028282612 @default.
- W2919906488 creator A5030461360 @default.
- W2919906488 creator A5030935161 @default.
- W2919906488 creator A5031614403 @default.
- W2919906488 creator A5032395863 @default.
- W2919906488 creator A5032623884 @default.
- W2919906488 creator A5032819263 @default.
- W2919906488 creator A5033607802 @default.
- W2919906488 creator A5033683577 @default.
- W2919906488 creator A5039438670 @default.
- W2919906488 creator A5043494441 @default.
- W2919906488 creator A5044132616 @default.
- W2919906488 creator A5050349781 @default.
- W2919906488 creator A5053312277 @default.
- W2919906488 creator A5057928180 @default.
- W2919906488 creator A5060965471 @default.
- W2919906488 creator A5063689892 @default.
- W2919906488 creator A5068573021 @default.
- W2919906488 creator A5069296340 @default.
- W2919906488 creator A5071744431 @default.
- W2919906488 creator A5072420401 @default.
- W2919906488 creator A5087697572 @default.
- W2919906488 creator A5090899159 @default.
- W2919906488 date "2019-05-01" @default.
- W2919906488 modified "2023-10-12" @default.
- W2919906488 title "The α2,3-selective potentiator of GABAA receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats" @default.
- W2919906488 cites W1481651962 @default.
- W2919906488 cites W1619186117 @default.
- W2919906488 cites W1967722500 @default.
- W2919906488 cites W2001619275 @default.
- W2919906488 cites W2009345240 @default.
- W2919906488 cites W2015488490 @default.
- W2919906488 cites W2016297143 @default.
- W2919906488 cites W2026229789 @default.
- W2919906488 cites W2028876012 @default.
- W2919906488 cites W2036008839 @default.
- W2919906488 cites W2040720903 @default.
- W2919906488 cites W2044138932 @default.
- W2919906488 cites W2054784843 @default.
- W2919906488 cites W2059410907 @default.
- W2919906488 cites W2064596734 @default.
- W2919906488 cites W2071304085 @default.
- W2919906488 cites W2073030228 @default.
- W2919906488 cites W2076849768 @default.
- W2919906488 cites W2077935936 @default.
- W2919906488 cites W2082798656 @default.
- W2919906488 cites W2087718200 @default.
- W2919906488 cites W2089387135 @default.
- W2919906488 cites W2097534444 @default.
- W2919906488 cites W2124835531 @default.
- W2919906488 cites W2139674907 @default.
- W2919906488 cites W2143848362 @default.
- W2919906488 cites W2144559699 @default.
- W2919906488 cites W2148597988 @default.
- W2919906488 cites W2149346574 @default.
- W2919906488 cites W2172201406 @default.
- W2919906488 cites W2212311707 @default.
- W2919906488 cites W2237245576 @default.
- W2919906488 cites W2275980576 @default.
- W2919906488 cites W2288630207 @default.
- W2919906488 cites W2406367148 @default.
- W2919906488 cites W2467052508 @default.
- W2919906488 cites W2515665586 @default.
- W2919906488 cites W2548227861 @default.
- W2919906488 cites W2549723544 @default.
- W2919906488 cites W2553945781 @default.
- W2919906488 cites W2582976680 @default.
- W2919906488 cites W2584799997 @default.
- W2919906488 cites W2587147839 @default.
- W2919906488 cites W2594766804 @default.
- W2919906488 cites W2607138535 @default.
- W2919906488 cites W2760117269 @default.
- W2919906488 cites W2775160102 @default.
- W2919906488 cites W2783527418 @default.
- W2919906488 cites W2799665185 @default.
- W2919906488 cites W2801031269 @default.
- W2919906488 cites W2883096177 @default.
- W2919906488 cites W2885694181 @default.
- W2919906488 cites W2894742715 @default.
- W2919906488 cites W2899304098 @default.
- W2919906488 cites W2912477090 @default.
- W2919906488 cites W2922011958 @default.
- W2919906488 doi "https://doi.org/10.1016/j.pbb.2019.02.013" @default.
- W2919906488 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6529285" @default.
- W2919906488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30825491" @default.
- W2919906488 hasPublicationYear "2019" @default.
- W2919906488 type Work @default.
- W2919906488 sameAs 2919906488 @default.
- W2919906488 citedByCount "23" @default.
- W2919906488 countsByYear W29199064882019 @default.
- W2919906488 countsByYear W29199064882020 @default.
- W2919906488 countsByYear W29199064882021 @default.
- W2919906488 countsByYear W29199064882022 @default.
- W2919906488 countsByYear W29199064882023 @default.